2023/10/04 17:38:00 | |
---|---|
Price | |
31.54 EUR | |
Difference | 0.57% (0.18) |
ISIN | ES0169501022 |
Symbol | PHM |
Exchange | BME Continuous Market |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 577 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 31.40 EUR |
High | 31.62 EUR |
Low | 31.28 EUR |
Close (prev. day) | 31.36 EUR |
VWAP | 31.452188 EUR |
Volume (pcs) | 18,475 |
Trading volume | 581,079.18 |
Number of trades | 364 |
Last size | - |
Related Futures | - |
Related Options | 1,003 |
Date | Headline | Download | |
2023/10/02 |
![]() |
Aktienempfehlungen Österreich |
![]() |
2023/09/29 |
![]() |
Global Equity Ratings |
![]() |
2023/09/29 |
![]() |
Aktienempfehlungen Global |
![]() |
2023/09/22 |
![]() |
Equity Weekly |
![]() |
2023/09/18 |
![]() |
Aktienempfehlungen Österreich |
![]() |
2023/10/04 17:38:00 | |
---|---|
Price | |
31.54 EUR | |
Difference | 0.57% (0.18) |
ISIN | ES0169501022 |
Symbol | PHM |
Exchange | BME Continuous Market |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 577 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 31.40 EUR |
High | 31.62 EUR |
Low | 31.28 EUR |
Close (prev. day) | 31.36 EUR |
VWAP | 31.452188 EUR |
Volume (pcs) | 18,475 |
Trading volume | 581,079.18 |
Number of trades | 364 |
Last size | - |
6m | 1y | 3y | |
Perf (%) | -26.55% | -44.06% | -71.69% |
Perf (abs.) | -11.40 | -24.84 | -79.86 |
Beta | 0.93 | 0.61 | 0.38 |
Volatility | 37.44 | 33.32 | 44.84 |
Ø price 5 days | Ø volume 5 days (pcs.) | 31.77 EUR (25,305) |
Ø price 30 days | Ø volume 30 days (pcs.) | 33.71 EUR (29,891) |
Ø price 100 days | Ø volume 100 days (pcs.) | 33.25 EUR (44,797) |
Ø price 250 days | Ø volume 250 days (pcs.) | 46.64 EUR (56,390) |
YTD High | date | 67.18 EUR (2023/01/03) |
YTD Low | date | 29.30 EUR (2023/07/07) |
52 Weeks High | date | 71.56 EUR (2022/12/09) |
52 Weeks Low | date | 29.30 EUR (2023/07/07) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2023/10/02 | 09:05 | 32.56 EUR | 0.00 | 3 |
Tradegate | 2023/10/04 | 22:02 | 31.68 EUR | 0.00 | 1 |
Stuttgart | 2023/10/04 | 12:07 | 31.50 EUR | 0.00 | 4 |
Munich | 2023/10/04 | 08:09 | 31.56 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2023/10/04 | 17:30 | 31.38 EUR | 0.00 | 2 |
Frankfurt | 2023/10/04 | 08:06 | 31.16 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2023/10/04 | 17:53 | 32.095 USD | 0.00 | 1 |
Duesseldorf | 2023/10/04 | 19:31 | 31.38 EUR | 0.00 | 5 |
Berlin | 2023/10/04 | 21:50 | 31.64 EUR | 0.00 | 17 |
BME Continuous Market | 2023/10/04 | 17:38 | 31.54 EUR | 0.58 | 364 |
PHARMA MAR SA |
- - |
Avenida de los Reyes, 1, Polígono Industrial La Mina - 28770 Colmenar Viejo |
Telefon: +34-91-846-60-00 |
Fax: +34-91-846-60-01 |
E-mail: pharmamar@pharmamar.com |
- |
José María Fernández Sousa-Faro | Chairman of Managing Board |
José Luis Moreno Martinez-Losa | Member of Executive Committee |
José Luis Ortega Conejero | Member of Executive Committee |
Juan Carlos Villalón Gomez | Member of Executive Committee |
Juan Gómez Pulido | Member of Executive Committee |
Luis Mora Capitán | Member of Executive Committee |
María Concepción Sanz | Member of Executive Committee |
María Luisa de Francia Caballero | Member of Executive Committee |
Sandra Llamera Sánchez | Member of Executive Committee |
Montserrat Andrade Detrell | Member of Supervisory Board |
Blanca Hernández Rodríguez | Member of Supervisory Board |
Carlos Pazos | Member of Supervisory Board |
Carlos Solchaga Catalán | Member of Supervisory Board |
Eduardo Serra Rexach | Member of Supervisory Board |
Emiliano Calvo Aller | Member of Supervisory Board |
Mariano Esteban Rodríguez | Member of Supervisory Board |
Martín-Delgado Fernando | Member of Supervisory Board |
Pedro Fernández Puentes | Member of Supervisory Board |
Rosa María Sánchez-Yebra Alonso | Member of Supervisory Board |
Sandra Ortega Mera | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.